Literature DB >> 24304333

Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes.

Ellen Phamduong1, Maanjot K Rathore, Nicholas R Crews, Alexander S D'Angelo, Andrew L Leinweber, Pranay Kappera, Thomas M Krenning, Victoria R Rendell, Mariana M Belcheva, Carmine J Coscia.   

Abstract

Chronic opioids induce synaptic plasticity, a major neuronal adaptation. Astrocyte activation in synaptogenesis may play a critical role in opioid tolerance, withdrawal, and dependence. Thrombospondins 1 and 2 (TSP1/2) are astrocyte-secreted matricellular glycoproteins that promote neurite outgrowth as well as dendritic spine and synapse formation, all of which are inhibited by chronic μ opioids. In prior studies, we discovered that the mechanism of TSP1 regulation by μ opioids in astrocytes involves crosstalk between three different classes of receptors, μ opioid receptor, EGFR and TGFβR. Moreover, TGFβ1 stimulated TSP1 expression via EGFR and ERK/MAPK activation, indicating that EGFR is a signaling hub for opioid and TGFβ1 actions. Using various selective antagonists, and inhibitors, here we compared the mechanisms of chronic opioid regulation of TSP1/2 isoform expression in vivo and in immortalized rat cortical astrocytes. TSP1/2 release from astrocytes was also monitored. Acute and chronic μ opioids, morphine, and the prototypic μ ligand, DAMGO, modulated TSP2 protein levels. TSP2 but not TSP1 protein content was up-regulated by acute (3 h) morphine or DAMGO by an ERK/MAPK dependent mechanism. Paradoxically, TSP2 protein levels were altered neither by TGFβ1 nor by astrocytic neurotrophic factors, EGF, CNTF, and BMP4. TSP1/2 immunofluorescence was increased in astrocytes subjected to scratch-wounding, suggesting TSPs may be useful markers for the "reactive" state of these cells and potentially for different types of injury. Previously, we determined that chronic morphine attenuated both neurite outgrowth and synapse formation in cocultures of primary astrocytes and neurons under similar temporal conditions that μ opioids reduced TSP1 protein levels in astrocytes. Here we found that, after the same 8 day treatment, morphine or DAMGO diminished TSP2 protein levels in astrocytes. Therefore, μ opioids may deter synaptogenesis via both TSP1/2 isoforms, but by distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24304333      PMCID: PMC3930990          DOI: 10.1021/cn400172n

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  66 in total

1.  Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential.

Authors:  Annalisa Buffo; Chiara Rolando; Stefania Ceruti
Journal:  Biochem Pharmacol       Date:  2009-09-16       Impact factor: 5.858

Review 2.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

3.  CD47 knockout mice exhibit improved recovery from spinal cord injury.

Authors:  Scott A Myers; William H DeVries; Kariena R Andres; Mark J Gruenthal; Richard L Benton; James B Hoying; Theo Hagg; Scott R Whittemore
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

4.  Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes.

Authors:  Rudolf Fuchshofer; Marco Birke; Ulrich Welge-Lussen; Daniel Kook; Elke Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

5.  Alpha-adrenergic stimulation of ERK phosphorylation in astrocytes is alpha(2)-specific and may be mediated by transactivation.

Authors:  Liang Peng; Albert C H Yu; King Y Fung; Vincent Prévot; Leif Hertz
Journal:  Brain Res       Date:  2003-07-18       Impact factor: 3.252

6.  Astrocyte secreted proteins selectively increase hippocampal GABAergic axon length, branching, and synaptogenesis.

Authors:  Ethan G Hughes; Sarina B Elmariah; Rita J Balice-Gordon
Journal:  Mol Cell Neurosci       Date:  2009-10-20       Impact factor: 4.314

7.  Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion.

Authors:  Teng-nan Lin; Gyoeng-Moon Kim; Jean-Ju Chen; Wai-Mui Cheung; Yong Y He; Chung Y Hsu
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

8.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

9.  Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.

Authors:  Mariana M Belcheva; Yun Tan; Virginia M Heaton; Amy L Clark; Carmine J Coscia
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

10.  The regulation of proenkephalin expression in a distinct population of glial cells.

Authors:  M H Melner; K G Low; R G Allen; C P Nielsen; S L Young; R P Saneto
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  6 in total

1.  Aquaporin 4 Forms a Macromolecular Complex with Glutamate Transporter 1 and Mu Opioid Receptor in Astrocytes and Participates in Morphine Dependence.

Authors:  Hui Wang; Shiqi Wang; Kang Zhang; Hua Wang; Liting Lan; Xiaoyun Ma; Xiaoyan Liu; Shuzhuo Zhang; Jianquan Zheng; Xiaoli Wei; Haitao Yan
Journal:  J Mol Neurosci       Date:  2017-03-24       Impact factor: 3.444

Review 2.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

3.  Role of GPCR (mu-opioid)-receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II).

Authors:  Dionéia Araldi; Luiz F Ferrari; Jon D Levine
Journal:  Pain       Date:  2018-05       Impact factor: 7.926

4.  Macroglia-derived thrombospondin 2 regulates alterations of presynaptic proteins of retinal neurons following elevated hydrostatic pressure.

Authors:  Shuchao Wang; Tu Hu; Zhen Wang; Na Li; Lihong Zhou; Lvshuang Liao; Mi Wang; Libin Liao; Hui Wang; Leping Zeng; Chunling Fan; Hongkang Zhou; Kun Xiong; Jufang Huang; Dan Chen
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

5.  Effects of cyanocobalamin and its combination with morphine on neuropathic rats and the relationship between these effects and thrombospondin-4 expression.

Authors:  Neslihan Düzenli; Sibel Ülker; Gülgün Şengül; Buse Kayhan; Aytül Önal
Journal:  Korean J Pain       Date:  2022-01-01

6.  Alterations in Excitatory and Inhibitory Synaptic Development Within the Mesolimbic Dopamine Pathway in a Mouse Model of Prenatal Drug Exposure.

Authors:  Taylor Boggess; James C Williamson; Ethan B Niebergall; Hannah Sexton; Anna Mazur; Richard D Egleton; Lawrence M Grover; W Christopher Risher
Journal:  Front Pediatr       Date:  2021-12-13       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.